297 related articles for article (PubMed ID: 12915559)
1. The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells.
Haas DL; Lutzko C; Logan AC; Cho GJ; Skelton D; Jin Yu X; Pepper KA; Kohn DB
J Virol; 2003 Sep; 77(17):9439-50. PubMed ID: 12915559
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Moloney murine leukemia virus stem cell-specific repressor binding site.
Kempler G; Freitag B; Berwin B; Nanassy O; Barklis E
Virology; 1993 Apr; 193(2):690-9. PubMed ID: 8460481
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to moloney murine leukemia virus-based vectors.
Barrette S; Douglas JL; Seidel NE; Bodine DM
Blood; 2000 Nov; 96(10):3385-91. PubMed ID: 11071632
[TBL] [Abstract][Full Text] [Related]
4. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
Kung SK; An DS; Chen IS
J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional Silencing of Moloney Murine Leukemia Virus in Human Embryonic Carcinoma Cells.
Wang GZ; Goff SP
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795446
[TBL] [Abstract][Full Text] [Related]
6. A stem cell-specific silencer in the primer-binding site of a retrovirus.
Petersen R; Kempler G; Barklis E
Mol Cell Biol; 1991 Mar; 11(3):1214-21. PubMed ID: 1996087
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
Moiani A; Miccio A; Rizzi E; Severgnini M; Pellin D; Suerth JD; Baum C; De Bellis G; Mavilio F
PLoS One; 2013; 8(1):e55721. PubMed ID: 23383272
[TBL] [Abstract][Full Text] [Related]
8. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
9. Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.
Cavazza A; Cocchiarella F; Bartholomae C; Schmidt M; Pincelli C; Larcher F; Mavilio F
Gene Ther; 2013 Sep; 20(9):949-57. PubMed ID: 23615186
[TBL] [Abstract][Full Text] [Related]
10. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors.
Salmon P; Kindler V; Ducrey O; Chapuis B; Zubler RH; Trono D
Blood; 2000 Nov; 96(10):3392-8. PubMed ID: 11071633
[TBL] [Abstract][Full Text] [Related]
11. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells.
Grez M; Zörnig M; Nowock J; Ziegler M
J Virol; 1991 Sep; 65(9):4691-8. PubMed ID: 1870196
[TBL] [Abstract][Full Text] [Related]
12. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.
Sun LQ; Warrilow D; Wang L; Witherington C; Macpherson J; Symonds G
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9715-9. PubMed ID: 7937878
[TBL] [Abstract][Full Text] [Related]
13. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells.
Grez M; Akgün E; Hilberg F; Ostertag W
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9202-6. PubMed ID: 2251265
[TBL] [Abstract][Full Text] [Related]
14. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
Rivière I; Brose K; Mulligan RC
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6733-7. PubMed ID: 7624312
[TBL] [Abstract][Full Text] [Related]
15. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters.
Malik P; Krall WJ; Yu XJ; Zhou C; Kohn DB
Blood; 1995 Oct; 86(8):2993-3005. PubMed ID: 7579392
[TBL] [Abstract][Full Text] [Related]
16. Isolation of high affinity cellular targets of the embryonal LTR binding protein, an undifferentiated embryonal carcinoma cell-specific repressor of Moloney leukemia virus.
Tsukiyama T; Niwa O
Nucleic Acids Res; 1992 Apr; 20(7):1477-82. PubMed ID: 1579438
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vector-mediated gene expression in human CD34+CD38- cells expanded in vitro: cis elements of FMEV are superior to those of Mo-MuLV.
Tsuji T; Itoh K; Baum C; Ohnishi N; Tomiwa K; Hirano D; Nishimura-Morita Y; Ostertag W; Fujita J
Hum Gene Ther; 2000 Jan; 11(2):271-84. PubMed ID: 10680841
[TBL] [Abstract][Full Text] [Related]
18. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells.
Wolf D; Goff SP
Cell; 2007 Oct; 131(1):46-57. PubMed ID: 17923087
[TBL] [Abstract][Full Text] [Related]
19. Long-term multilineage expression in peripheral blood from a Moloney murine leukemia virus vector after serial transplantation of transduced bone marrow cells.
Austin TW; Salimi S; Veres G; Morel F; Ilves H; Scollay R; Plavec I
Blood; 2000 Feb; 95(3):829-36. PubMed ID: 10648393
[TBL] [Abstract][Full Text] [Related]
20. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.
Bai Y; Soda Y; Izawa K; Tanabe T; Kang X; Tojo A; Hoshino H; Miyoshi H; Asano S; Tani K
Gene Ther; 2003 Aug; 10(17):1446-57. PubMed ID: 12900759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
